Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Seripa

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
Journal of the American Geriatrics Society|January 3, 2007
Apolipoprotein E genotypes in mild cognitive impairment subtypesGiuseppe Orsitto, Davide Seripa, Francesco Panza, et al.
Journal of the Neurological Sciences|June 2, 2017
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after strokeAndrea Santamato, Francesco Panza, Domenico Intiso, et al.
Current Alzheimer Research|May 20, 2011
Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumabFrancesco Panza, Vincenza Frisardi, Bruno P Imbimbo, et al.
Journal of the American Geriatrics Society|May 28, 2009
Possible predictors of vascular cognitive impairment-no dementiaFrancesco Panza, Vincenza Frisardi, Cristiano Capurso, et al.
Biomed Research International|February 14, 2014
Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairmentCarlo Cervellati, Arianna Romani, Davide Seripa, et al.
CNS Neuroscience & Therapeutics|June 22, 2010
REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current stateFrancesco Panza, Vincenza Frisardi, Bruno P Imbimbo, et al.
Expert Opinion on Pharmacotherapy|September 22, 2015
Progresses in treating agitation: a major clinical challenge in Alzheimer's diseaseFrancesco Panza, Vincenzo Solfrizzi, Davide Seripa, et al.
Expert Review of Neurotherapeutics|January 30, 2016
Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioniniumDavide Seripa, Vincenzo Solfrizzi, Bruno P Imbimbo, et al.
Journal of the American Geriatrics Society|May 1, 2009
Apolipoprotein E, dementia, and human longevityFrancesco Panza, Vincenza Frisardi, Cristiano Capurso, et al.
Rejuvenation Research|August 6, 2009
Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patientsAlberto Pilotto, Maria G Matera, Luigi Ferrucci, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
Journal of the American Geriatrics Society|January 3, 2007
Apolipoprotein E genotypes in mild cognitive impairment subtypesGiuseppe Orsitto, Davide Seripa, Francesco Panza, et al.
Journal of the Neurological Sciences|June 2, 2017
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after strokeAndrea Santamato, Francesco Panza, Domenico Intiso, et al.
Current Alzheimer Research|May 20, 2011
Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumabFrancesco Panza, Vincenza Frisardi, Bruno P Imbimbo, et al.
Journal of the American Geriatrics Society|May 28, 2009
Possible predictors of vascular cognitive impairment-no dementiaFrancesco Panza, Vincenza Frisardi, Cristiano Capurso, et al.
Biomed Research International|February 14, 2014
Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairmentCarlo Cervellati, Arianna Romani, Davide Seripa, et al.
CNS Neuroscience & Therapeutics|June 22, 2010
REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current stateFrancesco Panza, Vincenza Frisardi, Bruno P Imbimbo, et al.
Expert Opinion on Pharmacotherapy|September 22, 2015
Progresses in treating agitation: a major clinical challenge in Alzheimer's diseaseFrancesco Panza, Vincenzo Solfrizzi, Davide Seripa, et al.
Expert Review of Neurotherapeutics|January 30, 2016
Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioniniumDavide Seripa, Vincenzo Solfrizzi, Bruno P Imbimbo, et al.
Journal of the American Geriatrics Society|May 1, 2009
Apolipoprotein E, dementia, and human longevityFrancesco Panza, Vincenza Frisardi, Cristiano Capurso, et al.
Rejuvenation Research|August 6, 2009
Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patientsAlberto Pilotto, Maria G Matera, Luigi Ferrucci, et al.
Pageof 23